Witnessing the stock’s movement on the chart, on Wednesday, Larimar Therapeutics Inc (NASDAQ: LRMR) had a quiet start as it plunged -4.70% to $6.08, before settling in for the price of $6.38 at the close. Taking a more long-term approach, LRMR posted a 52-week range of $3.05-$13.68.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Meanwhile, its Annual Earning per share during the time was 48.33%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -41.50%. This publicly-traded company’s shares outstanding now amounts to $43.91 million, simultaneously with a float of $37.01 million. The organization now has a market capitalization sitting at $387.95 million. At the time of writing, stock’s 50-day Moving Average stood at $7.29, while the 200-day Moving Average is $8.13.
Larimar Therapeutics Inc (LRMR) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Larimar Therapeutics Inc’s current insider ownership accounts for 42.00%, in contrast to 60.89% institutional ownership. According to the most recent insider trade that took place on Feb 16 ’24, this organization’s Director bought 57,208 shares at the rate of 8.74, making the entire transaction reach 499,998 in total value, affecting insider ownership by 564,798. Preceding that transaction, on Feb 16 ’24, Company’s Director bought 4,290,617 for 8.74, making the whole transaction’s value amount to 37,499,993. This particular insider is now the holder of 6,151,406 in total.
Larimar Therapeutics Inc (LRMR) Earnings and Revenue Records
Larimar Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -41.50% and is forecasted to reach -1.55 in the upcoming year.
Larimar Therapeutics Inc (NASDAQ: LRMR) Trading Performance Indicators
Let’s observe the current performance indicators for Larimar Therapeutics Inc (LRMR). It’s Quick Ratio in the last reported quarter now stands at 13.10. The Stock has managed to achieve an average true range (ATR) of 0.67.
In the same vein, LRMR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.15, a figure that is expected to reach -0.31 in the next quarter, and analysts are predicting that it will be -1.55 at the market close of one year from today.
Technical Analysis of Larimar Therapeutics Inc (LRMR)
Going through the that latest performance of [Larimar Therapeutics Inc, LRMR]. Its last 5-days volume of 0.8 million indicated improvement to the volume of 0.59 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 7.64% While, its Average True Range was 0.70.
Raw Stochastic average of Larimar Therapeutics Inc (LRMR) in the period of the previous 100 days is set at 3.03%, which indicates a major fall in contrast to 4.47% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 110.69% that was higher than 81.46% volatility it exhibited in the past 100-days period.
